Tumor-promoting functions of adenosine
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abraham, 1993, The multidrug resistance (mdr1) gene product functions as an ATP channel, Proc Natl Acad Sci USA, 90, 312, 10.1073/pnas.90.1.312
Airas, 1996, CD73 mediates adhesion of B cells to follicular dendritic cells, Blood, 88, 1755, 10.1182/blood.V88.5.1755.1755
Airas, 1995, CD73 is involved in lymphocyte binding to the endothelium, J Exp Med, 182, 1603, 10.1084/jem.182.5.1603
Airas, 1997, Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells, J Cell Biol, 136, 421, 10.1083/jcb.136.2.421
Anastassiou, 1992, Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels, J Immunol, 148, 2845, 10.4049/jimmunol.148.9.2845
Apasov, 1998, The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase, Int Immunol, 11, 179, 10.1093/intimm/11.2.179
Arch, 1978, The control of the metabolism and the hormonal role of adenosine, Essays Biochem, 14, 82
Armstrong, 1988, Reduction of monocyte 5′-nucleotidase activity by gamma-interferon in multiple sclerosis and autoimmune diseases, Ann Neurol, 24, 12, 10.1002/ana.410240104
Averill, 1988, Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway, Cell Immunol, 115, 88, 10.1016/0008-8749(88)90164-5
Balis, 1985, Adenosine deaminase and malignant cells, Ann N Y Acad Sci, 451, 142, 10.1111/j.1749-6632.1985.tb27105.x
Barankiewicz, 1990, Extracellular ATP metabolism in B and T lymphocytes, Ann N Y Acad Sci, 603, 380, 10.1111/j.1749-6632.1990.tb37687.x
Barankiewicz, 1997, Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors, J Pharmacol Exp Ther, 283, 1230
Barcz, 1998, The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells, Oncol Rep, 5, 517
Bardot, 1994, Purine and pyrimidine metabolism in human gliomas, Br J Cancer, 70, 212, 10.1038/bjc.1994.282
Belardinelli, 1992, Does adenosine function as a retaliatory metabolite in the heart?, News Physiol Sci, 7, 52
Belardinelli, 1989, The cardiac effects of adenosine, Prog Cardiovasc Dis, 32, 73, 10.1016/0033-0620(89)90015-7
Berne, 1963, Cardiac nucleotides in hypoxia, Am J Physiol, 204, 317, 10.1152/ajplegacy.1963.204.2.317
Birch, 1986, Adenosine induced immunosuppression, Int J Immunopharmacol, 8, 329, 10.1016/0192-0561(86)90115-3
Blackburn, 1992, Adenosine levels in the postimplantation mouse uterus—quantitation by HPLC-fluorometric detection and spatiotemporal regulation by 5′-nucleotidase and adenosine deaminase, Dev Dyn, 194, 155, 10.1002/aja.1001940208
Bodin, 1995, Synergistic effect of acute hypoxia on flow-induced release of ATP from cultured endothelial cells, Experientia, 51, 256, 10.1007/BF01931108
Bodin, 1996, ATP-stimulated release of ATP by human endothelial cells, J Cardiovasc Pharmacol, 27, 872, 10.1097/00005344-199606000-00015
Bogenrieder, 1997, Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue, Prostate, 33, 225, 10.1002/(SICI)1097-0045(19971201)33:4<225::AID-PROS1>3.0.CO;2-G
Bontemps, 1983, Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes, Proc Natl Acad Sci USA, 80, 2829, 10.1073/pnas.80.10.2829
Bouma, 1994, Differential regulatory effects of adenosine on cytokine release by activated human monocytes, J Immunol, 153, 4159, 10.4049/jimmunol.153.9.4159
Bouma, 1996, Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells, Am J Physiol, 270, C522, 10.1152/ajpcell.1996.270.2.C522
Bouma, 1997, Adenosine inhibits neutrophil degranulation in activated human whole blood, J Immunol, 158, 5400, 10.4049/jimmunol.158.11.5400
Braun, 1998, Association of ecto-5′-nucleotidase with specific cell types in the adult and developing rat olfactory organ, J Comp Neurol, 393, 528, 10.1002/(SICI)1096-9861(19980420)393:4<528::AID-CNE10>3.0.CO;2-L
Braun, 1995, Distribution of 5′-nucleotidase in the developing mouse retina, Dev Brain Res, 88, 79, 10.1016/0165-3806(95)00082-O
Braun, 1997, Focal cerebral ischemia enhances glial expression of ecto-5′-nucleotidase, Brain Res, 766, 213, 10.1016/S0006-8993(97)00559-3
Braun, 1998, Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat, J Neurosci, 18, 4891, 10.1523/JNEUROSCI.18-13-04891.1998
Bui, 1997, A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas, Oncogene, 14, 1249, 10.1038/sj.onc.1200936
Caldwell, 1999, Ectonucleotidases of avian gizzard smooth muscle and liver plasma membranes, Arch Biochem Biophys, 362, 46, 10.1006/abbi.1998.1008
Canbolat, 1996, Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues, Breast Cancer Res Treat, 37, 189, 10.1007/BF01806500
Cetinkale, 1996, Neutrophil-mediated injury in ischemic skin flaps, Ann Plast Surg, 37, 66, 10.1097/00000637-199607000-00011
Che, 1997, Ectonucleotidases, purine nucleoside transporter, and function of the bile canalicular plasma membrane of the hepatocyte, FASEB J, 11, 101, 10.1096/fasebj.11.2.9039951
Cho-Chung, 1991, Role of site-selective cAMP analogs in the control and reversal of malignancy, Pharmacol Ther, 50, 1, 10.1016/0163-7258(91)90071-S
Christensen, 1992, Effects of immunomodulators on ecto-5′-nucleotidase activity on blood mononuclear cells in vitro, Scand J Immunol, 35, 407, 10.1111/j.1365-3083.1992.tb02875.x
Clark, 1993, Protein and enzyme content of plasma membranes derived from Walker 256 carcinoma cells grown as ascitic or solid tumors, Cancer Lett, 68, 91, 10.1016/0304-3835(93)90133-T
Corradetti, 1984, Adenosine decreases glutamate and aspartate release from rat hippocampal slices, Eur J Pharmacol, 104, 19, 10.1016/0014-2999(84)90364-9
Cotrina, 1998, Connexins regulate calcium signaling by controlling ATP release, Proc Natl Acad Sci USA, 95, 15735, 10.1073/pnas.95.26.15735
Coventry, 1996, Lack of IL-2 expression despite IL-2 messenger RNA transcription in tumor infiltrating lymphocytes in primary human breast carcinoma, J Immunol, 156, 3486, 10.4049/jimmunol.156.9.3486
Cronstein, 1992, Molecular mechanism of methotrexate action in inflammation, Inflammation, 16, 411, 10.1007/BF00918968
Cronstein, 1985, Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils, J Immunol, 135, 1366, 10.4049/jimmunol.135.2.1366
Cronstein, 1987, Engagement of adenosine receptors inhibits hydrogen peroxide (H2O2) release by activated human neutrophils, Clin Immunol Immunopathol, 42, 76, 10.1016/0090-1229(87)90174-7
Cronstein, 1991, Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells, Proc Natl Acad Sci USA, 88, 2441, 10.1073/pnas.88.6.2441
Cronstein, 1995, The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine, Arthritis Rheum, 38, 1040, 10.1002/art.1780380804
Cronstein, 1999, Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFκB, Proc Natl Acad Sci USA, 96, 6377, 10.1073/pnas.96.11.6377
Dang, 1990, Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways, J Immunol, 144, 4092, 10.4049/jimmunol.144.11.4092
Dasmahapatra, 1986, Evaluation of adenosine deaminase activity in patients with head and neck cancer, J Surg Res, 40, 368, 10.1016/0022-4804(86)90201-5
Decking, 1997, Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release, Circ Res, 8, 154, 10.1161/01.RES.81.2.154
Delaney, 1998, Levels of endogenous adenosine in rat striatum. II. Regulation of basal and N-methyl-d-aspartate-induced levels by inhibitors of adenosine transport and metabolism, J Pharmacol Exp Ther, 285, 568
Dinjens, 1990, Adenosine deaminase complexing protein (ADCP) expression and metastatic potential in prostatic adenocarcinomas, J Pathol, 160, 195, 10.1002/path.1711600303
Di Palo, 1993, Effect of cyclosporin A on renal cortical resistances measured by color doppler flowmetry on renal grafts, Nephron, 65, 240, 10.1159/000187481
Dong, 1996, Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response, J Immunol, 156, 1349, 10.4049/jimmunol.156.4.1349
Dornand, 1982, Ecto-5′nucleotidase and adenosine deaminase activities of lymphoid cells, Biochem Med, 28, 144, 10.1016/0006-2944(82)90065-5
Dunwiddie, 1994, Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses, J Pharmacol Exp Ther, 268, 537
Durak, 1994, Adenosine deaminase, 5′-nucleotidase, guanase and cytidine deaminase activities in gastric tissues from patients with gastric cancer, Cancer Lett, 84, 199, 10.1016/0304-3835(94)90376-X
Durak, 1994, Adenosine deaminase, 5′-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in cancerous and noncancerous human bladder tissues, Free Radic Biol Med, 16, 825, 10.1016/0891-5849(94)90199-6
Durak, 1997, Activity of the enzymes participating in purine metabolism of cancerous and noncancerous human kidney tissues, Cancer Invest, 15, 212, 10.3109/07357909709039717
Dusseau, 1988, Hypoxia-induced angiogenesis in chick chorioallantoic membranes, Respir Physiol, 71, 33, 10.1016/0034-5687(88)90113-2
Dzhandzhugazyan, 1998, Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas, FEBS Lett, 430, 227, 10.1016/S0014-5793(98)00603-6
Eigler, 1997, Endogenous adenosine curtails lipopolysaccharide-stimulated tumor necrosis factor synthesis, Scand J Immunol, 45, 132, 10.1046/j.1365-3083.1997.d01-377.x
Ely, 1992, Protective effects of adenosine in myocardial ischemia, Circulation, 85, 893, 10.1161/01.CIR.85.3.893
Ethier, 1993, Adenosine stimulates proliferation of human endothelial cells in culture, Am J Physiol, 265, H131
Fenoglio, 1997, Cytochemical demonstration of nitric oxide synthase and 5′ nucleotidase in human glioblastoma, Anticancer Res, 17, 2507
Finegan, 1996, Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischemia, Br J Pharmacol, 118, 355, 10.1111/j.1476-5381.1996.tb15410.x
Firestein, 1994, Protective effect of an adenosine kinase inhibitor in septic shock, J Immunol, 152, 5853, 10.4049/jimmunol.152.12.5853
Firestein, 1995, Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins, J Immunol, 154, 326, 10.4049/jimmunol.154.1.326
Flocke, 1991, Isolation and characterization of 5′-nucleotidase of a human pancreatic tumor cell line, Biochim Biophys Acta, 1076, 273, 10.1016/0167-4838(91)90278-8
Fukunaga, 1989, Increased density of ecto 5′ nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, Blood, 74, 2486, 10.1182/blood.V74.7.2486.2486
Gadangi, 1996, The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites, J Immunol, 156, 1937, 10.4049/jimmunol.156.5.1937
Garvey, 1998, Nucleotide and nucleoside analogues as inhibitors of cytosolic 5′-nucleotidase I from heart, Biochemistry, 37, 9043, 10.1021/bi980209d
Goldfeld, 1992, Transcription of the tumor necrosis factor-alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin-a and FK506 in human b-cells, Proc Natl Acad Sci USA, 89, 12198, 10.1073/pnas.89.24.12198
Grant, 1999, Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells, Circ Res, 85, 699, 10.1161/01.RES.85.8.699
Griffiths, 1993, Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts, J Mol Cell Cardiol, 25, 1461, 10.1006/jmcc.1993.1162
Gutensohn, 1983, Evaluation of 5′-nucleotidase as biochemical marker in leukemias and lymphomas, Klin Wochenschr, 61, 57, 10.1007/BF01484440
Handschin, 1979, Altered cellular ratio of type I and type II cyclic AMP-dependent protein kinase in human mammary tumors, FEBS Lett, 106, 301, 10.1016/0014-5793(79)80519-0
Hasko, 1996, Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice, J Immunol, 157, 4634, 10.4049/jimmunol.157.10.4634
Hazama, 1998, Cell surface measurements of ATP release from single pancreatic beta cells using a novel biosensor technique, Pflügers Arch, 437, 31, 10.1007/s004240050742
Headrick, 1989, 5′-Nucleotidase activity and adenosine formation in stimulated, hypoxic and underperfused rat heart, Biochem J, 261, 541, 10.1042/bj2610541
Herbschleb-Voogt, 1983, Adenosine deaminase complexing protein (ADCP), Anticancer Res, 3, 95
Hershfield, 1995, Immunodeficiency disease caused by adenosine deaminase deficiency and purine phosphorylase deficiency, 1725
Heurteaux, 1995, Essential role of adenosine A1 receptors, and ATP-sensitive K channels in cerebral ischemic preconditioning, Proc Natl Acad Sci USA, 92, 4666, 10.1073/pnas.92.10.4666
Huang, 1997, Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion, Blood, 90, 1600, 10.1182/blood.V90.4.1600
Hugo, 1992, In vitro effect of extracellular AMP on MCF-7 breast cancer cells, J Cell Physiol, 153, 539, 10.1002/jcp.1041530315
Janier, 1993, Adenosine protects ischemic and reperfused myocardium by receptor-mediated mechanism, Am J Physiol, 264, H163
Jiang, 1997, Adenosine kinase inhibition protects brain against transient focal ischemia in rats, Eur J Pharmacol, 320, 131, 10.1016/S0014-2999(96)00905-3
Kammer, 1986, Role of adenylate cyclase in human T-lymphocyte surface antigen capping, Cell Immunol, 101, 251, 10.1016/0008-8749(86)90202-9
Karasaki, 1980, Cell surface adenosine 5′-triphosphatase as an in vitro marker of the lineage and cytodifferentiation of oncogenic epithelial cells from rat liver parenchyma, Cancer Res, 40, 1318
Katsuragi, 1991, Existence of ATP-evoked ATP release system in smooth muscles, J Pharmacol Exp Ther, 259, 513
Kawano, 1989, The beneficial effect of cyclosporine on liver ischemia in rats, Transplantation, 48, 759, 10.1097/00007890-198911000-00007
Keil, 1994, Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice, Eur J Pharmacol, 271, 37, 10.1016/0014-2999(94)90262-3
Khoo, 1996, Differential expression of adenosine A1 receptors in colorectal cancer and related mucosa, Cancer Lett, 106, 17, 10.1016/0304-3835(96)04289-9
Kitakaze, 1993, Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs—implications for myocardial salvage, Circulation, 87, 208, 10.1161/01.CIR.87.1.208
Kitakaze, 1995, Alpha 1-adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C, Circulation, 91, 2226, 10.1161/01.CIR.91.8.2226
Kitakaze, 1996, Activation of ecto-5′-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes, J Mol Cell Cardiol, 28, 1945, 10.1006/jmcc.1996.0187
Kitakaze, 1996, Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase, Circulation, 93, 781, 10.1161/01.CIR.93.4.781
Kittel, 1994, Ecto-ATPases and 5′-nucleotidases in the caveolae of smooth muscle. Enzyme-histochemical evidence may indicate a role for caveolae in neurotransmission, Cell Biol Int, 18, 875, 10.1006/cbir.1994.1124
Knowles, 1995, The rat liver ecto-ATPase/C-CAM cDNA detects induction of carcinoembryonic antigen but not the mercurial-insensitive ecto-ATPase in human hepatoma Li-7A cells treated by epidermal growth factor and cholera toxin, Biochem Biophys Res Commun, 207, 529, 10.1006/bbrc.1995.1220
Kohring, 1998, Upregulation of ecto-5′-nucleotidase in human neuroblastoma SH-SY5Y cells on differentiation by retinoic acid and phorbol ester, Neurosci Lett, 258, 127, 10.1016/S0304-3940(98)00833-7
Kojima, 1985, Alteration of adenosine deaminase levels in peripheral blood lymphocytes of patients with gastric cancer, Jpn J Surg, 15, 130, 10.1007/BF02469742
Komoszynski, 1996, Apyrases (ATP diphosphohydrolases, EC 3.6.1.5), Biochim Biophys Acta, 1310, 233, 10.1016/0167-4889(95)00135-2
Korinek, 1997, Constitutive transcriptional activation by a beta-Catenin-Tcf complex in APC-/- colon carcinoma, Science, 275, 1784, 10.1126/science.275.5307.1784
Lappin, 1984, Adenosine A2 receptors on human monocytes modulate C2 production, Clin Exp Immunol, 57, 454
Ledoux, 1997, Overexpression of ecto-5′-nucleotidase promotes P-glycoprotein expression in renal epithelial cells, Kidney Int, 52, 953, 10.1038/ki.1997.417
Lelievre, 1998, Adenosine modulates cell proliferation in human colonic adenocarcinoma. I. Possible involvement of adenosine A1 receptor subtypes in HT29 cells, Eur J Pharmacol, 341, 289, 10.1016/S0014-2999(97)01462-3
Lelievre, 1998, Adenosine modulates cell proliferation in human colonic carcinoma. II. Differential behavior of HT29, DLD-1, Caco-2 and SW403 cell lines, Eur J Pharmacol, 341, 299, 10.1016/S0014-2999(97)01463-5
Le Moine, 1996, Adenosine enhances IL-10 secretion by human monocytes, J Immunol, 156, 4408, 10.4049/jimmunol.156.11.4408
Lin, 1990, ATP degradation and depletion of adenine nucleotides, 159
Lin, 1990, Liver plasma membrane ecto-ATPase, Ann N Y Acad Sci, 603, 394, 10.1111/j.1749-6632.1990.tb37688.x
Lloyd, 1995, Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices, Neurochem Int, 26, 387, 10.1016/0197-0186(94)00144-J
Ludwig, 1999, Expression of CD73 (ecto-5′-nucleotidase) in 165 glioblastoma by immunohistochemistry and electromicroscopic histochemistry, Anticancer Res, 19, 1747
Lutty, 1998, Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation, Curr Eye Res, 17, 594, 10.1080/02713689808951232
Ma, 1983, The role of purine metabolic enzymes and terminal deoxynucleotidyl transferase in intrathymic T-cell differentiation, Immunol Today, 4, 65, 10.1016/0167-5699(83)90120-2
MacKenzie, 1994, Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor, Cancer Res, 54, 3521
Madrid-Marina, 1990, Phorbol esters induce changes in adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyl transferase messenger RNA levels in human leukemic cell lines, Cancer Res, 50, 2891
Martinez-Valdez, 1988, Coordinate regulation of mRNAs encoding adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyltransferase by phorbol esters in human thymocytes, Proc Natl Acad Sci USA, 85, 6900, 10.1073/pnas.85.18.6900
Mazurek, 1997, Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates, J Biol Chem, 27, 4941, 10.1074/jbc.272.8.4941
McNally, 1997, Cloning and expression of the adenosine kinase gene from rat and human tissues, Biochem Biophys Res Commun, 231, 645, 10.1006/bbrc.1997.6157
McWhinney, 1996, Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alpha, Eur J Pharmacol, 310, 209, 10.1016/0014-2999(96)00272-5
Meininger, 1990, Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells, Am J Physiol, 258, H198
Miescher, 1987, Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors, J Immunol, 138, 4004, 10.4049/jimmunol.138.11.4004
Mitchell, 1998, A release mechanism for stored ATP in ocular ciliary epithelial cells, Proc Natl Acad Sci USA, 95, 7174, 10.1073/pnas.95.12.7174
Mitchell, 1999, A3 adenosine receptors regulate Cl- channels of nonpigmented ciliary epithelial cells, Am J Physiol, 276, C659, 10.1152/ajpcell.1999.276.3.C659
Morrison, 1993, A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase, J Exp Med, 177, 1135, 10.1084/jem.177.4.1135
Namiot, 1996, Adenosine deaminase activity in patients with the intestinal type of gastric carcinoma, Cancer Lett, 109, 199, 10.1016/S0304-3835(96)04445-X
Natori, 1992, Effects of theophylline on the selective increases in intratumoral blood flow induced by intracarotid infusion of adenosine and adenosine triphosphate in C6 glioma-transplanted rat brains, Surg Neurol, 37, 8, 10.1016/0090-3019(92)90058-U
Newby, 1990, Adenosine, News Physiol Sci, 5, 67
Nishinaka, 1993, Protective effect of FK506 on ischemia/reperfusion-induced myocardial damage in canine heart, J Cardiovasc Pharmacol, 21, 448, 10.1097/00005344-199303000-00015
Pak, 1994, Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices, Neuropharmacology, 33, 1049, 10.1016/0028-3908(94)90142-2
Parmely, 1993, Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge, J Immunol, 151, 389, 10.4049/jimmunol.151.1.389
Piroli, 1990, Subcellular distribution of cyclic adenosine 3′-5′-monophosphate-binding protein and estrogen receptors in control pituitaries and estrogen-induced pituitary tumors, J Natl Cancer Inst, 82, 596, 10.1093/jnci/82.7.596
Porat, 1988, Adenosine deaminase in cell transformation. Biophysical manifestation of membrane dynamics, J Biol Chem, 263, 14608, 10.1016/S0021-9258(18)68077-9
Prager, 1984, Effect of dimethylsulfoxide and butyrate on 5′-nucleotidase of human renal carcinoma cells, Cancer Lett, 24, 81, 10.1016/0304-3835(84)90083-1
Prat, 1996, Cellular ATP release by the cystic fibrosis transmembrane conductance regulator, Am J Physiol, 270, C538, 10.1152/ajpcell.1996.270.2.C538
Pueyo, 1998, Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells, Exp Cell Res, 238, 354, 10.1006/excr.1997.3864
Rajpert, 1987, Glucocorticoid receptors bound to the antagonist RU486 are not downregulated despite their capacity to interact in vitro with defined gene regions, J Steroid Biochem, 26, 513, 10.1016/0022-4731(87)90001-X
Rapaport, 1993, Anticancer activities of adenine nucleotides in tumor bearing hosts, Drug Dev Res, 28, 428, 10.1002/ddr.430280344
Rathbone, 1992, Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells, Neurosci Res, 13, 1, 10.1016/0168-0102(92)90030-G
Resnick, 1993, Activated eosinophils evoke chloride secretion in model intestinal epithelia primarily via regulated release of 5′-AMP, J Immunol, 151, 5716, 10.4049/jimmunol.151.10.5716
Richards, 1987, Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart, Circ Res, 61, 117, 10.1161/01.RES.61.1.117
Richardson, 1987, Ectoenzymes control adenosine modulation of immunoisolated cholinergic synapses, Nature, 327, 232, 10.1038/327232a0
Rosengren, 1995, Anti-Inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage, J Immunol, 154, 5444, 10.4049/jimmunol.154.10.5444
Rubinfeld, 1997, Stabilization of β-catenin by genetic defects in melanoma cell lines, Science, 275, 1790, 10.1126/science.275.5307.1790
Rudolphi, 1992, Neuroprotective role of adenosine in cerebral ischaemia, Trends Pharmacol Sci, 13, 439, 10.1016/0165-6147(92)90141-R
Rynning, 1995, Endogenous adenosine attenuates myocardial stunning by antiadrenergic effects exerted during ischemia and not during reperfusion, J Cardiovasc Pharmacol, 25, 432, 10.1097/00005344-199503000-00013
Sajjadi, 1996, Inhibition of TNF-alpha expression by adenosine, J Immunol, 156, 3435, 10.4049/jimmunol.156.9.3435
Sala-Newby, 1999, The mechanism of adenosine formation in cells. Cloning of cytosolic 5′-nucleotidase-I, J Biol Chem, 274, 17789, 10.1074/jbc.274.25.17789
Savic, 1990, Induction of ecto-5′-nucleotidase of rat cultured mesangial cells by interleukin-1beta and tumor necrosis factor-alfa, Immunology, 70, 321
Schoen, 1994, Synaptic 5′-nucleotidase activity reflects lesion-induced sprouting within the adult rat dentate gyrus, Exp Neurol, 127, 106, 10.1006/exnr.1994.1084
Schoen, 1991, Synaptic 5′-nucleotidase is transient and indicative of climbing fiber plasticity during the postnatal development of rat cerebellum, Dev Brain Res, 61, 125, 10.1016/0165-3806(91)90122-Y
Schrader, 1990, Adenosine. A homeostatic metabolite in cardiac energy metabolism, Circulation, 81, 389, 10.1161/01.CIR.81.1.389
Schwiebert, 1995, CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP, Cell, 81, 1063, 10.1016/S0092-8674(05)80011-X
Shi, 1994, Prevalence of the mercurial-sensitive EctoATPase in human small cell lung carcinoma, Arch Biochem Biophys, 315, 177, 10.1006/abbi.1994.1487
Siegfried, 1995, Parathyroid hormone stimulates ecto-5′-nucleotidase activity in renal epithelial cells, Endocrinology, 136, 1267, 10.1210/en.136.3.1267
Snyder, 1982, Kinetic considerations for the regulation of adenosine and deoxyadenosine metabolism in mouse and human tissues based on a thymocyte model, Biochim Biophys Acta, 696, 299, 10.1016/0167-4781(82)90061-6
Specchia, 1985, Adenosine deaminase activity in peripheral lymphocytes of patients with gynaecologic malignancies, Boll Ist Sieroter Milan, 64, 404
Spielman, 1982, A proposed role for adenosine in the regulation of renal hemodynamics and renin release, Am J Physiol, 242, F423
Spychala, 1987, Adenine nucleotide metabolism in isolated chicken hepatocytes, Biochem J, 242, 551, 10.1042/bj2420551
Spychala, 1996, Cloning of human adenosine kinase cDNA, Proc Natl Acad Sci USA, 93, 1232, 10.1073/pnas.93.3.1232
Spychala, 1997, Adenosine metabolism during phorbol myristate acetate-mediated induction of HL-60 cell differentiation, J Immunol, 158, 4947, 10.4049/jimmunol.158.10.4947
Spychala, 1999, Tissue-specific regulation of the ecto-5′-nucleotidase promoter, J Biol Chem, 274, 22705, 10.1074/jbc.274.32.22705
Szabo, 1998, Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists, Br J Pharmacol, 125, 379, 10.1038/sj.bjp.0702040
Tamesue, 1998, ATP release caused by bradykinin, substance P and histamine from intact and cultured smooth muscles of guinea-pig vas deferens, Naunyn Schmiedebergs Arch Pharmacol, 357, 240, 10.1007/PL00005163
Taylor, 1998, Bioluminescence detection of ATP release mechanisms in epithelia, Am J Physiol, 275, C1391, 10.1152/ajpcell.1998.275.5.C1391
Thompson, 1983, Ecto-5′-nucleotidase activity in human T cell subsets, J Clin Invest, 71, 892, 10.1172/JCI110843
Thompson, 1986, Ecto-5′-nucleotidase expression during human B cell development. An explanation for the heterogeneity in B lymphocyte ecto-5′-nucleotidase activity in patients with hypogammaglobulinemia, J Immunol, 137, 2496, 10.4049/jimmunol.137.8.2496
Thompson, 1989, Antibodies to 5′-nucleotidase (Cd73), a glycosyl-phosphatidylinositol-anchored protein, cause human peripheral blood T-cells to proliferate, J Immunol, 143, 1815, 10.4049/jimmunol.143.6.1815
Trotta, 1978, Characterization of adenosine deaminase from normal colon and colon tumors. Evidence for tumor specific variants, Biochemistry, 17, 270, 10.1021/bi00595a013
Ujhazy, 1994, Ecto-5′-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin, Int J Cancer, 59, 83, 10.1002/ijc.2910590117
Ujhazy, 1996, Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance, Int J Cancer, 68, 493, 10.1002/(SICI)1097-0215(19961115)68:4<493::AID-IJC15>3.0.CO;2-6
Velu, 1993, In vivo induction of IL-10 by anti-CD3 monoclonal antibody in mice, Transplant Proc, 25, 568
Vider, 1996, Evidence for the involvement of the Wnt 2 gene in human colorectal cancer, Oncogene, 12, 153
Vigne, 1998, Analysis of the influence of nucleotidases on the apparent activity of exogenous ATP and ADP at P2Y1 receptors, Br J Pharmacol, 125, 675, 10.1038/sj.bjp.0702115
Vogel, 1993, Transient association of the HNK-1 epitope with 5′-nucleotidase during development of the cat visual cortex, Eur J Neurosci, 5, 1423, 10.1111/j.1460-9568.1993.tb00209.x
Wenzel-Seifert, 1991, Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation, J Immunol, 147, 1940, 10.4049/jimmunol.147.6.1940
Wesley, 1999, A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells, J Exp Med, 190, 311, 10.1084/jem.190.3.311
Wiendl, 1998, Nucleotide metabolizing ectoenzymes are upregulated in A431 cells periodically treated with cytostatic ATP leading to partial resistance without preventing apoptosis, Biochim Biophys Acta, 1404, 282, 10.1016/S0167-4889(98)00040-8
Williams, 1997, Adenosine acts through a novel extracellular receptor to inhibit granule exocytosis by natural killer cells, Biochem Biophys Res Commun, 231, 264, 10.1006/bbrc.1997.6077
Wilson, 1999, ATP release mechanisms in primary cultures of epithelia derived from the cysts of polycystic kidneys, J Am Soc Nephrol, 10, 218, 10.1681/ASN.V102218
Wu, 1982, Adenosine receptor agonists inhibit K-evoked and Ca uptake by rat brain cortical synaptosomes, J Neurochem, 39, 700, 10.1111/j.1471-4159.1982.tb07949.x
Wyatt, 1989, Adenosine stimulates glycolytic flux in isolated perfused rat hearts by A-1-adenosine receptors, Am J Physiol, 257, H1952
Xaus, 1999, IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages, J Immunol, 162, 3607, 10.4049/jimmunol.162.6.3607
Yang, 1994, Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells, Circ Res, 74, 401, 10.1161/01.RES.74.3.401
Zhang, 1998, Lymphoid cell infiltration during breast cancer growth, Immunol Cell Biol, 76, 550, 10.1046/j.1440-1711.1998.00780.x